# Andrew Fisher

> Andrew Fisher is a Series A investor backing Medical and Life Science. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Location: Brighton, United Kingdom
- Total investments: 1
- Last investment: May 2018
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/andrewsfisher
- X (Twitter): http://twitter.com/andrewfisher

Andrew Fisher is a Series A investor in Brighton focused on Medical and Life Science. As an Executive Vice President at Wesley Clover, Andrew currently manages a portfolio of ICT and Digital Media companies globally. In addition he also acts as a business prime for the Wesley Clover affiliate program.Andrew connects teams of new graduates with tier one Network Operator, Service Provider and Communications EquipmentManufactures globally. These partnerships provide invaluable customer insight and a route to market for each of the Affiliates. Through these partnerships, each party realizes time to revenue, time to market and engine for innovation advantage.Andrew serves on the Board of Directors for March Entertainment, Benbria and Teldio Corporations. He is also a member of the Advisory board for the Canadian Digital Media Network and the Canadian Department of Foreign Affairs and International Trade Information and Communications Technologies.Andrew is an honors graduate from the University of British Columbia, with an academic background in Computer Science, Engineering and Economics.

## Contacts

5 contacts available for Andrew Fisher: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/andrew-fisher-4?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MIP Diagnostics | MIP Diagnostics Ltd was founded in 2015 as a spin out from the University of Leicester by several leading experts in the field, including Prof. Sergey Piletsky, in order to commercialise various forms of Molecularly Imprinted Polymers (MIPs), sometimes called "plastic antibodies". Their proprietary technology includes a novel method tomake nanoMIPs which circumvents the drawbacks of traditional MIP manufacturing methods. NanoMIPS are, as the name suggests, nanostructured polymer particles typically containing a single binding site for their target. Whilst MIPs are exceptionally robust polymers [plastics], nanoMIPS are sufficiently small to be essentially soluble. They can also be fused to solid substrates, such as sensor surfaces, if required. The robust nature of MIPs and nanoMIPs make them ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing. | $2M | Series A | May 08, 2018 | http://www.mip-dx.com/ |

1 of 1 investments shown.

## Co-investors
- [Mercia Fund Managers](https://shizune.co/investors/profile/mercia-fund-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Life Science Angel Investors in United Kingdom](https://shizune.co/investors/life-science-angel-investors-united-kingdom)
- [Life Science Angel Investors in Europe](https://shizune.co/investors/life-science-angel-investors-europe)
- [Medical Angel Investors in United Kingdom](https://shizune.co/investors/medical-angel-investors-united-kingdom)

## FAQ

### What does Andrew Fisher invest in?

Andrew Fisher invests primarily in Medical, Life Science and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Andrew Fisher?

Public channels for Andrew Fisher include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Andrew Fisher last invest?

The most recent investment recorded for Andrew Fisher closed in May 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co